Research theme for competitive and other funds (3):
2020 - 2024 A novel germline mutation in the non-coding region of BRCA2 is associated with hereditary breast cancer
2020 - 2023 Combination treatment with CDC7 inhibitor and DNA damage agents enhances antiproliferative activity in multiple preclinical models
2019 - 2022 Single-cell analyses reveal diverse mechanisms of resistance to EGFR-TKI in lung cancer
Papers (28):
Yuma Takano, Jun Suzuki, Kotaro Nomura, Gento Fujii, Junko Zenkoh, Hitomi Kawai, Yuta Kuze, Yukie Kashima, Satoi Nagasawa, Yuka Nakamura, et al. Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development. Nature communications. 2024. 15. 1. 10637-10637
Motohiro Izumi, Masanori Fujii, Ikei S Kobayashi, Vivian Ho, Yukie Kashima, Hibiki Udagawa, Daniel B Costa, Susumu S Kobayashi. Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. Cell death & disease. 2024. 15. 8. 580-580
Atsushi Motegi, Shun-Ichiro Kageyama, Yukie Kashima, Hidenari Hirata, Hidehiro Hojo, Masaki Nakamura, Takeshi Fujisawa, Tomohiro Enokida, Makoto Tahara, Kazuto Matsuura, et al. Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current oncology (Toronto, Ont.). 2024. 31. 8. 4397-4405
Shigeru Fujita, Arnon Plianchaisuk, Sayaka Deguchi, Hayato Ito, Naganori Nao, Lei Wang, Hesham Nasser, Tomokazu Tamura, Izumi Kimura, Yukie Kashima, et al. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236. EBioMedicine. 2024. 104. 105181-105181
Yukie Kashima, Patrick Reteng, Yasuhiko Haga, Junya Yamagishi, Yutaka Suzuki. Single-cell analytical technologies: uncovering the mechanisms behind variations in immune responses. The FEBS journal. 2024. 291. 5. 819-831